These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2177316)

  • 1. Properties of a 9-(2-phosphonylmethoxyethyl)adenine (PMEA)-resistant herpes simplex virus type 1 virus mutant.
    Vonka V; Anisimová E; Cerný J; Holý A; Rosenberg I; Votruba I
    Antiviral Res; 1990 Aug; 14(2):117-21. PubMed ID: 2177316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative activity of various compounds against clinical strains of herpes simplex virus.
    Andrei G; Snoeck R; Goubau P; Desmyter J; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):143-51. PubMed ID: 1327785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphonylmethyl ethers of acyclic nucleoside analogues: inhibitors of HSV-1 induced ribonucleotide reductase.
    Cerný J; Votruba I; Vonka V; Rosenberg I; Otmar M; Holý A
    Antiviral Res; 1990 May; 13(5):253-64. PubMed ID: 2168691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus-specified DNA polymerase is the target for the antiviral action of 9-(2-phosphonylmethoxyethyl)adenine.
    Foster SA; Cerny J; Cheng YC
    J Biol Chem; 1991 Jan; 266(1):238-44. PubMed ID: 1845964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phosphonylmethoxyalkyl-purine and -pyrimidine derivatives on TK+ and TK- HSV-1 keratitis in rabbits.
    Maudgal PC; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):93-100. PubMed ID: 1663731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sensitivities to other antiviral drugs and thymidine kinase activity of aciclovir-resistant herpes simplex virus type 1].
    Nitta K; Shiota H; Naito T; Mimura Y
    Nippon Ganka Gakkai Zasshi; 1994 Jun; 98(6):513-9. PubMed ID: 8030564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of resistance to acycloguanosine and acycloguanosine H-phosphonate in herpes simplex virus].
    Andronova VL; Galegov GA; Ias'ko MV; Kukhanova MK; Skoblov IuS
    Vopr Virusol; 2010; 55(1):31-4. PubMed ID: 20364669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis.
    Boisjoly HM; Park NH; Pavan-Langston D; De Clercq E
    Arch Ophthalmol; 1983 Nov; 101(11):1782-6. PubMed ID: 6314952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
    Aduma P; Connelly MC; Srinivas RV; Fridland A
    Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
    Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
    Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents.
    Neyts J; De Clercq E
    Antimicrob Agents Chemother; 1998 Jan; 42(1):170-2. PubMed ID: 9449280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of herpes simplex virus DNA polymerase by diphosphates of acyclic phosphonylmethoxyalkyl nucleotide analogues.
    Merta A; Votruba I; Rosenberg I; Otmar M; Hrebabecký H; Bernaerts R; Holý A
    Antiviral Res; 1990 May; 13(5):209-18. PubMed ID: 2168689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo.
    De Clercq E; Holý A; Rosenberg I
    Antimicrob Agents Chemother; 1989 Feb; 33(2):185-91. PubMed ID: 2719463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
    Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
    J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 9-(2-phosphonylmethoxyethyl)adenine in the therapy of TK+ and TK- herpes simplex virus experimental keratitis.
    Maudgal PC; De Clercq E
    Curr Eye Res; 1991; 10 Suppl():139-42. PubMed ID: 1650660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication.
    Neyts J; De Clercq E
    Biochem Pharmacol; 1994 Jan; 47(1):39-41. PubMed ID: 8311844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Docherty JJ; Dobson AT; Trimble JJ; Jennings BA
    Intervirology; 1991; 32(5):308-15. PubMed ID: 1657822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.
    Perno CF; Balestra E; Aquaro S; Panti S; Cenci A; Lazzarino G; Tavazzi B; Di Pierro D; Balzarini J; Calio R
    Mol Pharmacol; 1996 Aug; 50(2):359-66. PubMed ID: 8700144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.